8. REMUNERATION REPORT – AUDITED
RAMSAY HEALTH CARE LIMITED
3.4 Five year Group performance correlated to variable reward outcomes
The graph and table below summarises STI and LTI outcomes over the past 5 years together with share price, dividend and NPAT performance
demonstrating the alignment of at-risk reward outcomes and shareholder outcomes.
FY17 FY18 FY19 FY20 FY21
STI LTI Dividend EPS
FY21 FY20 FY19 FY18 FY17
CEO STI outcomes (% of maximum) 88 - 90 70 93.6
CEO LTI outcomes (% of maximum) - - 37 45 97
Closing share price at end of period ($) 62.95 66.52 72.24 53.98 73.60
Dividends per Ordinary Shares ($) 1.5150 0.6250 1.5150 1.4400 1.3450
NPAT ($M) 449.00 284.00 545.50 388.30 488.90
3.5 Actual remuneration table (Executive KMP)
The table below provides a summary of the actual take-home pay received by Executive KMP during FY21. Unlike the statutory remuneration
tables in section 3.6 below, the below table has not been prepared in accordance with the requirements of the Australian Accounting Standards
and is unaudited. It is included on a voluntary basis to show what Executive KMP actually received in FY21, and amounts that are paid or vested
to executives in FY21 (with an FY20 for comparison).
Name Financial Year FAR1 ($)
payments ($) STI Awarded2 ($) LTI Vested ($)
FY21 2,131,330 - 2,294,490 - 4,425,820
FY20 2,141,654 - - - 2,141,654
M.J. Roberts3 FY21 1,200,000 207,403 642,000 - 2,049,403
FY20 240,909 - - - 240,929
FY21 240,172 - 120,000 - 360,172
FY20 985,596 - - - 985,596
1 FAR includes cash salary, superannuation and non-monetary benefits such as private health insurance cover and motor vehicle running costs.
2 STI represents the amount awarded for FY21 noting that 50% is deferred into equity for 3 years for the CEO, and 1 and 2 years for the CFO.
3 Mr Roberts commenced 20 April 2020 so amounts for FY20 relate to the period 20 April to 30 June 2020. In joining Ramsay, Mr Roberts forfeited unvested equity from his prior role. In
recognition of this, the Group CFO was provided with performance rights equivalent to $1M that vest subject to meeting individual performance requirements and service conditions over
the 3 years from his employment anniversary. On 20 April 2021 20% or 3,074 of the Rights vested, with a vesting date value of $207,403.
4 Mr Sims ceased as Executive KMP on 30 September 2020. The FY21 remuneration details included within the table above reflect amounts paid to Mr Sims during his service period as a
member of the Executive KMP only.
Annual Report 2021 49